Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of add-on topiramate in patients with difficult-to-treat epilepsy and partial-onset seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Epilepsies, Partial | Phase 2 | Status: COMPLETED